Skip to content

Clinical trials

Completed Urinary Bladder Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Status: Completed Country / region: South Korea Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20081
20091
20101
20111
20121
20132
20143
20153
20164
20173
20185
20193
20203
20212
20224
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center5
Seoul National University Hospital5
Bristol-Myers Squibb3
Bayer2
Hoffmann-La Roche2
Janssen Research & Development, LLC2
Merck Sharp & Dohme LLC2
Yonsei University2
Astellas Pharma Global Development, Inc.1
Astellas Pharma Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms42
Carcinoma, Transitional Cell10
Colorectal Neoplasms4
Lung Neoplasms4
Neoplasms4
Ovarian Neoplasms4
Prostatic Neoplasms4
Ureteral Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.